Is the prophylaxis of patent ductus arteriosus useful in extremely premature infants?

Turkish Journal of Pediatrics

Volumn 53, Issue 2, 2011, Pages 187-193

  Bersani, Iliana ^a   de Carolis, Maria Pia ^a   Lacerenza, Serafina ^a   de Rosa, Gabriella ^a   Fusco, Francesca Paola ^a   Cota, Francesco ^a   Romagnoli, Costantino ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

COX inhibitor; Extremely premature infants; Ibuprofen; Patent ductus arteriosus; Prophylaxis

Indexed keywords

IBUPROFEN; IBUPROFEN LYSINE; INDOMETACIN;

ARTERY LIGATION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GESTATIONAL AGE; HUMAN; HYPOXEMIA; INFANT; INTERVENTION STUDY; INTESTINE PERFORATION; LOADING DRUG DOSE; LUNG HEMORRHAGE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; THROMBOCYTOPENIA;

COHORT STUDIES; CYCLOOXYGENASE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE;

EID: 80052039298     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Saf 2001; 24: 537-551.
2. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549-554.
3. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733-738.
4. Romagnoli C, De Carolis MP, Papacci P, et al. Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates. Clin Pharmacol Ther 2000; 67: 676-683.
5. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26 (Suppl): S14-18.
6. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (1): CD004213; 28 February 2009 Updated.
7. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113-1121.
8. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991; 119: 417-423.
9. Gagliardi L, Macagno F, Pedrotti D, et al. Standard antropometrici neonatali prodotti dalla task force della Società Italiana di Neonatologia e basati su una popolazione italiana nordorientale. Riv Ital Ped 1999; 25: 59-69.
10. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based on clinical staging. Ann Surg 1978; 187: 1-7.
11. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529-534.
12. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2008 23;(1): CD003481.
13. Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1945-1949.
14. Dani C, Bertini G, Pezzati M, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005; 115: 1529-1535.
15. Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939-1944.
16. Dani C, Bertini G, Corsini I, et al. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta Paediatr 2008; 97: 1176-1180.
17. Chorne N, Jegatheesan P, Lin E, Shi R, Clyman RI. Risk factors for persistent ductus arteriosus patency during indomethacin treatment. J Pediatr 2007; 151: 629-634.
18. Kajino H, Goldbarg S, Roman C, et al. Vasa vasorum hypoperfusion is responsible for medial hypoxia and anatomic remodeling in the newborn lamb ductus arteriosus. Pediatr Res 2002; 51: 228-235.
19. Madan J, Fiascone J, Balasubramanian V, Griffith J, Hagadorn JI. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin. Neonatology 2008; 94: 45-51.
20. Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996; 128: 601-607.
21. Momma K, Toyono M. The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 1999; 46: 311-315.
22. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006; 89: 330-335.
23. Gournay V, Savagner C, Thiriez G, Kuster A, Rozé JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 359: 1486-1488.
24. Kluckow M, Evans N, Leslie G, Rowe J. Prostacyclin concentrations and transitional circulation in preterm infants requiring mechanical ventilation. Arch Dis Child Fetal Neonatal Ed 1999; 80: F34-37.
25. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations. J Perinatol 2006; 26: 185-188.
26. Menozzi A, Pozzoli C, Giovannini E, et al. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat. Eur J Pharmacol 2006; 552: 143-150.
27. Richards J, Johnson A, Fox G, Campbell M. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 2009; 124: e287-293.
28. Su BH, Watanabe T, Shimizu M, Yanagisawa M. Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child Fetal Neonatal Ed 1997; 77: F36-40.